Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Latest filing published 07 Jul 2014 for Furiex Pharmaceuticals, Inc..
Insider track record
Disclosed buys
0
Disclosed sells
5
Signal history
No signal scores available.
Stephen W. Kaldor: trading record in brief
Stephen W. Kaldor appears in our data through filings on Furiex Pharmaceuticals, Inc. shares, published by SEC (Form 4). The record holds 12 filings, for trades running from 11 March 2013 to 2 July 2014.
Every open-market trade on record is a sale: 5 sales worth €457k. Other entries cover 2 share grants and 4 option exercises.
Most recently, on 7 July 2014, the filings show a transaction in Furiex Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Stephen W. Kaldor
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
7,160 sharesCommon StockSEC:0001437749-14-012505:0
3,580 shares0Common StockSEC:0001437749-14-003387:0
3,580 shares0Common StockSEC:0001437749-13-006831:0
5,379 shares@ US$13.94Common StockSEC:0001181431-13-017026:0
973 shares@ US$13.94Common StockSEC:0001181431-13-017026:2
1,648 shares@ US$13.94Common StockSEC:0001181431-13-017026:4
1,648 shares@ US$39.96Common StockSEC:0001181431-13-017026:5
8,000 shares@ US$13.94Common StockSEC:0001181431-13-016742:0
5,379 shares@ US$41.74Common StockSEC:0001181431-13-016742:1
973 shares@ US$40.71Common StockSEC:0001181431-13-016742:2
10 of 10 declarations
